Concourse Financial Group Securities’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 659 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2734 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2728 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2772 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2786 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2744 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2759 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2767 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2768 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2711 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2493 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2583 |
|
|
2022
Q1 | – | Sell |
-2,800
| Closed | -$106K | – | 2543 |
|
|
2021
Q4 | $106K | Buy |
2,800
+2,692
| +2,493% | +$102K | 0.01% | 970 |
|
|
2021
Q3 | $4K | Hold |
108
| – | – | ﹤0.01% | 2095 |
|
|
2021
Q2 | $7K | Hold |
108
| – | – | ﹤0.01% | 1953 |
|
|
2021
Q1 | $6K | Hold |
108
| – | – | ﹤0.01% | 1905 |
|
|
2020
Q4 | $9K | Buy |
108
+8
| +8% | +$667 | ﹤0.01% | 1706 |
|
|
2020
Q3 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 1675 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2363 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2437 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2364 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2064 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2484 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2493 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2361 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1897 |
|